Cordavis to stay in CVS Health after bifurcation of $117bn empire
CVS Health will keep biosimilar subsidiary Cordavis under its umbrella, after the company announced plans to split off its pharmacy…
News
Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinic
Evommune signs $1.1bn licence deal with Hinova for EVO570
PharmatrophiX and Circular partner on neurodegenerative drugs
Trump’s healthcare plans under contention after Democrats’ midterm landslide
Boehringer signs oncology deal with Sino Biopharm worth up to $7.4bn
AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera
GEBRO and Spektus sign collaboration for ActraFlex
